A New Frameshift Mutation of PTEN Gene Associated with Cowden Syndrome—Case Report and Brief Review of the Literature

• Published in: Genes Vol. 14; no. 10; p. 1909
• Main Authors: Jurca, Claudia Maria, Frățilă, Ovidiu, Iliaș, Tiberia, Jurca, Aurora, Cătana, Andreea, Moisa, Corina, Jurca, Alexandru Daniel
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 05.10.2023; MDPI
• Subjects: Acne; Autosomal dominant inheritance; Bioinformatics; Cancer; Case Report; Case reports; Clinical aspects; Colon; Cowden syndrome; Diagnosis; Disease; Embryogenesis; Evolution; Frameshift mutation; Gastroenterology; Genes; Genetic testing; hamartomas; Hormones; Interdisciplinary aspects; intestinal polyps; Intestine; Laboratories; Literature reviews; Mutation; Patients; Phosphatase; Polyps; Proteins; PTEN gene; PTEN protein; Quality control; Thoracic surgery; Thyroid gland
• ISSN: 2073-4425; 2073-4425
• DOI: 10.3390/genes14101909

Cowden syndrome (CS) is a rare disease that was first described in 1963 and later included in the large group of genodermatoses. It is the most common syndrome among the PTEN-associated hamartomatous tumor syndromes (PHTS). CS has an autosomal dominant inheritance pattern, with increased penetrance and variable expressivity, making early diagnosis difficult. Mutations in the PTEN gene (phosphatase and TENsin homolog) are involved in its pathogenesis, involving many organs and systems originating in the three embryonic layers (ectodermum, endodermum, and mesodermum). The consequence is the development of hamartomatous lesions in various organs (brain, intestines, thyroid, oropharyngeal cavity, colon, rectum, etc.). Multiple intestinal polyps are common in patients with CS, being identified in over 95% of patients undergoing colonoscopy. The authors describe the case of a patient who presented the first signs of the disease at 3 ½ years (tonsil polyp) but was diagnosed only at the age of 20 following a colonoscopy that revealed hundreds of intestinal polyps, suggesting further molecular testing. A heterozygous frameshift mutation was identified in the PTEN gene, classified as a potentially pathogenic variant (c.762del.p(Val255*)). The authors present this case to highlight the path taken by the patient from the first symptoms to the diagnosis and to emphasize the clinical aspects of this mutational variant that have still not been identified in other patients with this syndrome.